Evaluating sleep quality in young cancer survivors
Assessment of Sleep Quality in Patients Treated for Cancer Between 15 and 24 Years of Age
NA · Centre Hospitalier Universitaire de Nice · NCT06904495
This study is trying to see how well young cancer survivors aged 15 to 24 sleep after their treatment and what factors might affect their sleep quality.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 400 (estimated) |
| Ages | 15 Years to 24 Years |
| Sex | All |
| Sponsor | Centre Hospitalier Universitaire de Nice (other) |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (Nice) |
| Trial ID | NCT06904495 on ClinicalTrials.gov |
What this trial studies
This study assesses the sleep quality of cancer survivors aged 15 to 24 years who were treated for cancer. It aims to understand the long-term impacts of cancer treatments on sleep disorders in this age group, which is often overlooked. Participants will complete a questionnaire to evaluate their sleep quality and related factors. The study focuses on those who have completed their intensive cancer treatment at least three months prior and are being followed at a specialized cancer center.
Who should consider this trial
Good fit: Ideal candidates are cancer survivors aged 15 to 24 who completed their treatment at least three months ago and are being followed at a designated cancer center.
Not a fit: Patients with major cognitive impairments or those unable to use computer tools may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved management and treatment of sleep disorders in young cancer survivors.
How similar studies have performed: While there is limited research specifically on sleep quality in this demographic, studies on sleep disorders in cancer survivors have shown varying degrees of success in addressing related issues.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient treated for a cancer * Patient aged between 15 and 24 years old at the time of the diagnosis * Patients whom intensive treatment ended at least 3 months ago * Patient followed in a PACAAURA cancerology center * Life expectancy ≥ 6 months * Karnosky index \> 60% * Patient who agrees to participate in the program and benefits from social security * Patient able to understand, speak and read French. * No major cognitive impairment (assessed by the patient's referees) * No sensory disability Exclusion Criteria: * Patient unable to use informatic tools * Known superior cognitive function disorders * Progressive psychiatric pathology * Drug user or alcohol abuse
Where this trial is running
Nice
- CHU de Nice — Nice, France (RECRUITING)
Study contacts
- Study coordinator: Meryl Horwitz, Dr
- Email: horwitez.m@chu-nice.fr
- Phone: 492036795
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Cancer Survivors